Hypertension, Vol 8, 1058-1066, Copyright © 1986 by American Heart Association
FF Vincenzi, CD Morris, LB Kinsel, M Kenny and DA McCarron
Several operationally defined adenosine triphosphatase (ATPase) activities
were determined in vitro in red blood cell lysates of normotensive or
hypertensive humans: Mg2+-ATPase, Na+,K+-ATPase, and Ca2+ pump ATPase, the
latter in the calmodulin-activated and basal states. Basal Ca2+ pump ATPase
was defined as the Ca2+-activated ATPase resistant to 10(-4) M
trifluoperazine. Subjects were part of a double- blind study in which
treatment was divided into several phases: baseline (4 weeks), placebo or
calcium (1 g elemental calcium/day, 8 weeks), placebo washout (4 weeks),
placebo or calcium (1 g elemental calcium/day, 8 weeks). Irrespective of
the phase of treatment, the basal Ca2+ pump ATPase activity in red blood
cell lysates of 36 hypertensive subjects was significantly less than that
in lysates from 18 normotensive subjects. Other ATPase activities did not
differ significantly, although all ATPases tended to be decreased in
hypertension. The data are consistent with previous reports of altered
membrane Ca2+ binding and transport in hypertension, but the precise
changes are not elucidated.
ARTICLES
Decreased calcium pump adenosine triphosphatase in red blood cells of hypertensive subjects
This article has been cited by other articles:
![]() |
B. Grunfeld, M. Gimenez, M. Romo, L. Rabinovich, and R. B. Simsolo Calcium-ATPase and Insulin in Adolescent Offspring of Essential Hypertensive Parents Hypertension, December 1, 1995; 26(6): 1070 - 1073. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |